JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, C. A.
Right arrow Articles by Nuss, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, C. A.
Right arrow Articles by Nuss, G. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 141, Issue 3, 369-376, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics

ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDO-METHACIN, 1-(p-CHLOROBENZOYL)-5-METHOXY-2-METHYL-INDOLE-3-ACETIC ACID

Charles A. Winter 1, Edwin A. Risley 1, and George W. Nuss 1

1 Merck Institute for Therapeutic Research, West Point, Pennsylvania

Indomethacin, 1-(p-chlorobenzoyl) - 5 methoxy-2-methylindole-3-acetic acid, is a potent anti-inflammatory and antipyretic compound. It is orally active as an inhibitor of cotton pellet granuloma formation in the rat, with a potency about 85 times that of phenylbutazone and about 4 times that of hydrocortisone. It is equally active in intact or adrenalectomized rats and is effective when applied directly to the cotton pellet. When used in conjunction with a steroid, the action of the latter is enhanced. Indomethacin is also a potent inhibitor of edema induced in the rat's foot by subplantar injection of carrageenin. The compound is an active antipyretic drug, with potency 10 to 20 times that of phenylbutazone.

Submitted on February 27, 1963
Accepted on May 21, 1963




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
H. Utsumi, K. Yasukawa, T. Soeda, K.-i. Yamada, R. Shigemi, T. Yao, and M. Tsuneyoshi
Noninvasive Mapping of Reactive Oxygen Species by in Vivo Electron Spin Resonance Spectroscopy in Indomethacin-Induced Gastric Ulcers in Rats
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 228 - 235.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Stoeck, R. Riedel, G. Hochhaus, D. Hafner, J. M. Masso, B. Schmidt, A. Hatzelmann, D. Marx, and D. S. Bundschuh
In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 249 - 258.
[Abstract] [Full Text]

Home page
 ScienceHome page
F. Kuehl Jr and R. Egan
Prostaglandins, arachidonic acid, and inflammation
Science, November 28, 1980; 210(4473): 978 - 984.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.